2019
DOI: 10.1016/j.bbrc.2019.08.151
|View full text |Cite
|
Sign up to set email alerts
|

M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 22 publications
1
3
0
Order By: Relevance
“…Additionally, KEGG research demonstrated that it may be associated with gap junctions, EGFR tyrosine kinase inhibitor resistance, Rap1 signaling pathway, and regulation of the actin cytoskeleton. These mechanisms are similar to the calcium release channel activity described previously [44][45][46][47][48]. This strongly suggests that the circRNAs found in the ceRNA network may play an essential role in the etiology of HCM.…”
Section: Plos Onesupporting
confidence: 85%
“…Additionally, KEGG research demonstrated that it may be associated with gap junctions, EGFR tyrosine kinase inhibitor resistance, Rap1 signaling pathway, and regulation of the actin cytoskeleton. These mechanisms are similar to the calcium release channel activity described previously [44][45][46][47][48]. This strongly suggests that the circRNAs found in the ceRNA network may play an essential role in the etiology of HCM.…”
Section: Plos Onesupporting
confidence: 85%
“…One of our aims is to understand how changes in the cardiac actin gene (ACTC) lead to different cardiomyopathies. We have conducted molecular-level studies on several ACTC variants [5][6][7][8][9], however, our ultimate goal is to integrate our molecular knowledge of ACTC biochemical changes with physiological dysfunction by editing the cardiac actin gene in an animal model.…”
Section: Introductionmentioning
confidence: 99%
“…We seek to understand how changes in the cardiac actin gene (ACTC) in people lead to different cardiomyopathies. We have studied several ACTC variants at the molecular level [5][6][7][8][9] ; however, our goal is to integrate our molecular knowledge of ACTC biochemical changes with physiological dysfunction in a whole animal by gene editing the cardiac actin gene in the model organism.…”
Section: Introductionmentioning
confidence: 99%